Research on breast cancer has reported that interfering with RhoC gene expression could inhibit the proliferation and infiltration abilities of tumor cells through a mechanism that likely involves the simultaneous downregulation of matrix metalloproteinase‐9 (MMP‐9).25 The ECM primarily exists between cells, and therefore, angiogenesis requires the degradation of the ECM. Here, MMP9 is linked to breast carcinoma.